Inositol metabolism in Trypanosoma cruzi: potential target for chemotherapy against Chagas' disease
AUTOR(ES)
OLIVEIRA, MECIA M., EINICKER-LAMAS, MARCELO
FONTE
Anais da Academia Brasileira de Ciências
DATA DE PUBLICAÇÃO
2000-09
RESUMO
Chagas' disease is a debilitating and often fatal disease caused by the protozoan parasite Trypanosoma cruzi. The great majority of surface molecules in trypanosomes are either inositol-containing phospholipids or glycoproteins that are anchored into the plasma membrane by glycosylphosphatidylinositol anchors. The polyalcohol myo-inositol is the precursor for the biosynthesis of these molecules. In this brief review, recent findings on some aspects of the molecular and cellular fate of inositol in T. cruzi life cycle are discussed and identified some points that could be targets for the development of parasite-specific therapeutic agents.
Documentos Relacionados
- The pentose phosphate pathway in Trypanosoma cruzi: a potential target for the chemotherapy of Chagas disease
- Search for a platelet-activating factor receptor in the Trypanosoma cruzi proteome: a potential target for Chagas disease chemotherapy
- Serological diagnosis of Chagas' disease: a potential confirmatory assay using preserved protein antigens of Trypanosoma cruzi.
- PCR-based detection of Trypanosoma cruzi useful for specific diagnosis of human Chagas' disease.
- Immunoglobulin A antibodies to Trypanosoma cruzi antigens in digestive forms of Chagas' disease.
